Growing numbers of patients, consuming cannabinoids admitted to surgery, create a challenge to anesthesia providers.
Seth Rogen announced the launch of his cannabis brand and the internet loved it so much, the site immediately went down. The actor/filmmaker/stoner and his longtime creative partner, Evan Goldberg, announced the launch of their cannabis company Houseplant on Monday. The name combines the brand’s two main products: “House” goods like ceramic ashtrays and lighters,…
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
France is Europe’s biggest cannabis consumer, despite having some of the continent’s toughest laws against the drug.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. In this context, patients and their physicians have had an increasing number of conversations about the risks and benefits of cannabis.
The agriculture domain in Israel has always been a source of national pride for many years, but over the past two decades, there has been a significant decline in the industry’s profitability and prestige.
About a year ago, I was talking to the guy behind herbclub.org and one of his supportive friends, Herbies, about how they came to build a site dedicated to connecting cannabis enthusiasts and he mentioned his personal experiences with cannabis as medicine in the treatment of your brain injury.
Did you know that 5% of the world’s population carry the trait genes that contribute to hemoglobin disorders like sickle-cell disease?
Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program
Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation.